Atrial Fibrillation Risk Assessment after Embolic Stroke of Undetermined Source.
Aenne Solvejg von FalkenhausenKatharina FeilMoritz F SinnerSonja SchöneckerJohanna MüllerJohannes WischmannElodie EiffenerSebastian ClaussSven PoliKhouloud PoliChristine S ZuernUlf ZiemannJörg BerrouschotAlkisti KitsiouWolf-Rüdiger SchäbitzMarianne DieterichSteffen MassbergStefan KääbLars KellertPublished in: Annals of neurology (2022)
The novel, non-invasive, electrocardiogram-based rhythm irregularity burden may help adjudicating AF risk after ESUS, and subsequently guide AF-detection after ESUS. Clinical trials need to clarify if high-AF risk patients benefit from tailored secondary stroke prevention. ANN NEUROL 2022.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- left atrial
- catheter ablation
- left atrial appendage
- end stage renal disease
- clinical trial
- risk assessment
- direct oral anticoagulants
- heart failure
- chronic kidney disease
- percutaneous coronary intervention
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- acute coronary syndrome
- blood pressure
- heart rate
- venous thromboembolism
- double blind
- phase iii